HK1087336A1 - Pharmaceutical composition comprising lumiracoxib - Google Patents

Pharmaceutical composition comprising lumiracoxib

Info

Publication number: HK1087336A1
Authority: HK; Hong Kong
Prior art keywords: tablets; lumiracoxib; administration; pharmaceutical composition; fluoroanilino
Prior art date: 2001-08-31

Application number

HK06107694.8A

Other languages

English (en)

Inventor

Anees Abdulquadar Karnachi

Simon David Bateman

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-31

Filing date

2006-07-10

Publication date

2006-10-13

2006-07-10 Application filed by Novartis Ag filed Critical Novartis Ag

2006-10-13 Publication of HK1087336A1 publication Critical patent/HK1087336A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HK06107694.8A 2001-08-31 2006-07-10 Pharmaceutical composition comprising lumiracoxib HK1087336A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31638901P	2001-08-31	2001-08-31
PCT/EP2002/009701 WO2003020261A1 (fr)	2001-08-31	2002-08-30	Composition pharmaceutique comprenant du lumiracoxib

Publications (1)

Publication Number	Publication Date
HK1087336A1 true HK1087336A1 (en)	2006-10-13

Family

ID=23228840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK06107694.8A HK1087336A1 (en)	2001-08-31	2006-07-10	Pharmaceutical composition comprising lumiracoxib

Country Status (30)

Country	Link
US (2)	US20030114527A1 (fr)
EP (1)	EP1425005B1 (fr)
JP (1)	JP4636796B2 (fr)
KR (1)	KR100895551B1 (fr)
CN (1)	CN100406008C (fr)
AR (1)	AR036312A1 (fr)
AT (1)	ATE324883T1 (fr)
AU (1)	AU2002331094B2 (fr)
BR (1)	BR0212155A (fr)
CA (1)	CA2456604C (fr)
CO (1)	CO5560554A2 (fr)
CY (1)	CY1106137T1 (fr)
DE (1)	DE60211183T2 (fr)
DK (1)	DK1425005T3 (fr)
EC (1)	ECSP044986A (fr)
ES (1)	ES2263813T3 (fr)
HK (1)	HK1087336A1 (fr)
HU (1)	HUP0401429A2 (fr)
IL (1)	IL160375A0 (fr)
MX (1)	MXPA04001933A (fr)
MY (1)	MY137516A (fr)
NO (1)	NO20040860L (fr)
NZ (1)	NZ531342A (fr)
PE (1)	PE20030323A1 (fr)
PL (1)	PL367464A1 (fr)
PT (1)	PT1425005E (fr)
RU (1)	RU2329801C2 (fr)
SI (1)	SI1425005T1 (fr)
WO (1)	WO2003020261A1 (fr)
ZA (1)	ZA200400877B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20020351A1 (es) *	2000-09-11	2002-06-14	Novartis Ag	Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
GB0201520D0 (en) *	2002-01-23	2002-03-13	Novartis Ag	Pharmaceutical uses
KR20040089654A (ko) *	2002-03-07	2004-10-21	노파르티스 아게	약제학적 조성물
EP2334378B1 (fr)	2008-08-19	2014-04-09	XenoPort, Inc.	Prodrogues du fumarate de mono-méthyle, compositions pharmaceutiques à base de celles-ci, et procédés d'utilisation
US20140093563A1 (en) *	2011-06-13	2014-04-03	Ranbaxy Laboratories Limited	Febuxostat compositions
EP2851075B1 (fr)	2012-05-14	2021-12-01	Shionogi & Co., Ltd.	Préparation contenant un dérivé de 7-carbamoylmorphinane 6,7-insaturé
CA2882713A1 (fr)	2012-08-22	2014-02-27	Xenoport, Inc.	Methodes d'administration du monomethyl fumarate et des promedicaments associes presentant des effets secondaires reduits
WO2014031897A1 (fr)	2012-08-22	2014-02-27	Xenoport, Inc.	Formes pharmaceutiques orales possédant une charge élevée de (n,n-diéthylcarbamoyl)méthyl méthyl(2e)but-2-ène-l,4-dioate
EA018867B1 (ru) *	2012-11-01	2013-11-29	Лаборатория Тютор С.А.С.И.Ф.И.А.	Способ получения фармацевтической композиции и продукт способа
US10179118B2 (en)	2013-03-24	2019-01-15	Arbor Pharmaceuticals, Llc	Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (fr)	2013-06-07	2014-12-11	Xenoport, Inc.	Procédé de production de monométhylfumarate
US9421182B2 (en)	2013-06-21	2016-08-23	Xenoport, Inc.	Cocrystals of dimethyl fumarate
TW201516020A (zh)	2013-09-06	2015-05-01	Xenoport Inc	（ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
WO2015105992A1 (fr) *	2014-01-10	2015-07-16	Mcneil-Ppc, Inc.	Procédé pour fabriquer un comprimé par radiofréquence et particules revêtues à perte
US9999672B2 (en)	2014-03-24	2018-06-19	Xenoport, Inc.	Pharmaceutical compositions of fumaric acid esters
EP3162362A1 (fr) *	2015-10-30	2017-05-03	Dr. Falk Pharma Gmbh	Comprimé optimisé a une haute dose contenant de la mesalazine
US10493026B2 (en)	2017-03-20	2019-12-03	Johnson & Johnson Consumer Inc.	Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08511009A (ja) *	1993-06-08	1996-11-19	チバ−ガイギーアクチェンゲゼルシャフト	ジクロフェナックを含有する経口固体剤形の製造方法
AU3004997A (en) *	1996-05-17	1997-12-09	Merck & Co., Inc.	Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
CO4960662A1 (es) *	1997-08-28	2000-09-25	Novartis Ag	Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
PE20020351A1 (es) *	2000-09-11	2002-06-14	Novartis Ag	Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2

2002
- 2002-08-29 PE PE2002000832A patent/PE20030323A1/es not_active Application Discontinuation
- 2002-08-29 US US10/231,438 patent/US20030114527A1/en not_active Abandoned
- 2002-08-29 AR ARP020103257A patent/AR036312A1/es unknown
- 2002-08-30 RU RU2004109920/15A patent/RU2329801C2/ru not_active IP Right Cessation
- 2002-08-30 KR KR1020047002925A patent/KR100895551B1/ko not_active IP Right Cessation
- 2002-08-30 DE DE60211183T patent/DE60211183T2/de not_active Expired - Lifetime
- 2002-08-30 NZ NZ531342A patent/NZ531342A/en not_active IP Right Cessation
- 2002-08-30 SI SI200230367T patent/SI1425005T1/sl unknown
- 2002-08-30 PT PT02767455T patent/PT1425005E/pt unknown
- 2002-08-30 CA CA2456604A patent/CA2456604C/fr not_active Expired - Fee Related
- 2002-08-30 MY MYPI20023252A patent/MY137516A/en unknown
- 2002-08-30 AT AT02767455T patent/ATE324883T1/de active
- 2002-08-30 CN CNB02816895XA patent/CN100406008C/zh not_active Expired - Fee Related
- 2002-08-30 IL IL16037502A patent/IL160375A0/xx unknown
- 2002-08-30 PL PL02367464A patent/PL367464A1/xx not_active Application Discontinuation
- 2002-08-30 MX MXPA04001933A patent/MXPA04001933A/es active IP Right Grant
- 2002-08-30 AU AU2002331094A patent/AU2002331094B2/en not_active Ceased
- 2002-08-30 WO PCT/EP2002/009701 patent/WO2003020261A1/fr active IP Right Grant
- 2002-08-30 BR BR0212155-7A patent/BR0212155A/pt not_active IP Right Cessation
- 2002-08-30 DK DK02767455T patent/DK1425005T3/da active
- 2002-08-30 JP JP2003524569A patent/JP4636796B2/ja not_active Expired - Fee Related
- 2002-08-30 ES ES02767455T patent/ES2263813T3/es not_active Expired - Lifetime
- 2002-08-30 EP EP02767455A patent/EP1425005B1/fr not_active Expired - Lifetime
- 2002-08-30 HU HU0401429A patent/HUP0401429A2/hu unknown
2004
- 2004-02-03 ZA ZA200400877A patent/ZA200400877B/en unknown
- 2004-02-25 CO CO04016658A patent/CO5560554A2/es not_active Application Discontinuation
- 2004-02-25 EC EC2004004986A patent/ECSP044986A/es unknown
- 2004-02-26 NO NO20040860A patent/NO20040860L/no not_active Application Discontinuation
2006
- 2006-07-10 HK HK06107694.8A patent/HK1087336A1/xx not_active IP Right Cessation
- 2006-08-03 CY CY20061101093T patent/CY1106137T1/el unknown
2007
- 2007-05-17 US US11/804,284 patent/US20070231382A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20040031019A (ko)	2004-04-09
IL160375A0 (en)	2004-07-25
NZ531342A (en)	2005-09-30
ZA200400877B (en)	2004-11-01
ECSP044986A (es)	2004-04-28
PT1425005E (pt)	2006-09-29
CA2456604A1 (fr)	2003-03-13
DE60211183D1 (de)	2006-06-08
WO2003020261A1 (fr)	2003-03-13
CN1728993A (zh)	2006-02-01
RU2329801C2 (ru)	2008-07-27
AU2002331094B2 (en)	2006-08-31
JP2005520785A (ja)	2005-07-14
NO20040860L (no)	2004-04-22
HUP0401429A2 (hu)	2004-11-29
ATE324883T1 (de)	2006-06-15
JP4636796B2 (ja)	2011-02-23
PE20030323A1 (es)	2003-05-12
KR100895551B1 (ko)	2009-04-29
CO5560554A2 (es)	2005-09-30
US20030114527A1 (en)	2003-06-19
BR0212155A (pt)	2004-07-13
DK1425005T3 (da)	2006-09-04
SI1425005T1 (sl)	2006-12-31
ES2263813T3 (es)	2006-12-16
CA2456604C (fr)	2011-02-08
DE60211183T2 (de)	2007-02-01
MY137516A (en)	2009-02-27
EP1425005B1 (fr)	2006-05-03
CY1106137T1 (el)	2011-06-08
EP1425005A1 (fr)	2004-06-09
CN100406008C (zh)	2008-07-30
PL367464A1 (en)	2005-02-21
US20070231382A1 (en)	2007-10-04
MXPA04001933A (es)	2004-06-15
RU2004109920A (ru)	2005-04-20
AR036312A1 (es)	2004-08-25

Publication	Publication Date	Title
HK1087336A1 (en)	2006-10-13	Pharmaceutical composition comprising lumiracoxib
BG106251A (en)	2002-08-30	Levodopa (carbidopa) entacapone pharmaceutical preparation
WO2004112711A3 (fr)	2005-05-19	Composition orale a liberation prolongee
IS7006A (is)	2003-10-30	Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
WO2009045795A3 (fr)	2009-07-16	Formulations galéniques de composés organiques
CA2411882A1 (fr)	2001-12-27	Compositions pharmaceutiques
CA2383212A1 (fr)	2001-03-08	Dosage oral a liberation regulee destine a l'administration orale
ES2130081B1 (es)	2000-01-01	Comprimido de maleato de trimebutina con recubrimiento laminar.
MXPA06000332A (es)	2006-03-30	Nueva composicion farmaceutica solida que comprende amisulprida.
CA2416771A1 (fr)	2002-03-14	Acide 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetique pour le traitement de troubles relies au cox-2
MXPA04003506A (es)	2004-07-23	Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
MXPA05008843A (es)	2005-10-18	Sistema terapeutico que comprende amoxicilina y acido clavulanico.
MY130445A (en)	2007-06-29	Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2003099214A3 (fr)	2004-08-12	Formulations de biguanide
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
IL164763A0 (en)	2005-12-18	Byperforin derivatives, the use thereof and formulations containing them
WO2004073627A3 (fr)	2004-11-18	Methode et compositions therapeutiques pour administration topique
HK1075390A1 (en)	2005-12-16	Citalopram for the treatment of elevated blood pressure
AU2001295839A1 (en)	2002-05-15	Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
HUP0200148A2 (hu)	2002-05-29	N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére

Legal Events

Date	Code	Title	Description
2013-03-28	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20120830